Related references
Note: Only part of the references are listed.B cell elimination in systemic lupus erythematosus
Joao Furtado et al.
CLINICAL IMMUNOLOGY (2013)
The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease
L. E. Harward et al.
LUPUS (2013)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides
Maryam Piram et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases
Vanessa M. Bugni et al.
JORNAL DE PEDIATRIA (2012)
Usefulness of Cellular Text Messaging for Improving Adherence Among Adolescents and Young Adults with Systemic Lupus Erythematosus
Tracy V. Ting et al.
JOURNAL OF RHEUMATOLOGY (2012)
Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test
C. Drenkard et al.
LUPUS (2012)
Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring
M. F. Marengo et al.
LUPUS (2012)
Concomitant cyclophosphamide and oral immunosuppressants with rituximab for systemic lupus erythematosus
Edward M. Vital et al.
RHEUMATOLOGY (2012)
Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients
Frederic A. Houssiau
ARTHRITIS RESEARCH & THERAPY (2012)
Mycophenolate mofetil in the treatment of systemic lupus erythematosus
Maria Dall'Era
CURRENT OPINION IN RHEUMATOLOGY (2011)
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation
Tabitha Turner-Stokes et al.
RHEUMATOLOGY (2011)
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus
TJA Lehman et al.
JOURNAL OF PEDIATRICS (2000)
Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers
H Amano et al.
LUPUS (2000)